February 1, 2006
View Full Paper1,026 Experimental treatments in acute stroke
Key Points
Key points are not available for this paper at this time.
Abstract
The results question whether the most efficacious drugs are being selected for stroke clinical trials. This may partially explain the slow progress in developing treatments. Greater rigor in the conduct, reporting, and analysis of animal data will improve the transition of scientific advances from bench to bedside.